The US Food and Drug Administration has authorized three OTC COVID-19 antigen diagnostic tests after providing templates to help developers provide necessary data and information in support of pre-emergency use authorization submissions.
The agency’s Center for Devices and Radiological Health (CDRH) on 22 November announced emergency use authorizations (EUAs) for home-use COVID-19 antigen diagnostic tests for people 14 and older with a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?